Enablex (darifenacin) Extended Release Tablet, 15 mg per tablet. Physician Sample 7 Tablets bottle, Rx only, Mfd by: Novartis Pharma Stein AG, Stein, Switzerland, NDC 0078-9420-07
Published August 7, 2013 · Recall initiated: May 17, 2013
Summary
FDA records drug Class II recall D-822-2013, published August 7, 2013 and initiated May 17, 2013. Recalling firm: Warner Chilcott US LLC; Status: Terminated; Reported quantity: 188,600 bottles; Lot: Lot F1002 - Exp.12/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: unspecified degradation product
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Warner Chilcott US LLC
- Distributor
- Nationwide
- Lot
- Lot F1002 - Exp.12/13
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABelladonna Alkaloids/PB (Belladonna Alkaloids / Phenobarbital) Tablets Phenobarbital USP 16.2 mg, HyoscyamineAugust 7, 2013
- FDADayQuil Sinex DayTime Sinus Relief (acetaminophen 325 mg and phenylephrine HCl 5 mg) liquicaps and NyQuilAugust 7, 2013
- FDANight Bullet Capsules, supplied in 1 count packets, produced by Green Planet Inc, Riverside, CAAugust 7, 2013
- FDASodium Bicarbonate, USP Provided bulk as raw material - label not applicable according to firm Dialysis GradeJuly 31, 2013
- FDAMedtronic Preimplantation Test Kit, Catalog No. 21047. The kit is indicated for use with Medtronic CSF-FlowJuly 31, 2013
- FDAAdvanced Orthogonal Percussion Adjusting Instrument Indicated for use by a licensed Chiropractor to assist inJuly 31, 2013
Questions about this recall
Was Enablex (darifenacin) Extended Release Tablet, 15 mg per tablet. Physician Sample 7 Tablets bottle, Rx only, Mfd by: Novartis Pharma Stein AG, Stein, Switzerland, NDC 0078-9420-07 recalled?
Yes. FDA published recall D-822-2013 on August 7, 2013. Reported hazard: Failed Impurities/Degradation Specifications: unspecified degradation product
What should I do if I have this product?
Voluntary: Firm initiated · Letter